Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-3982.39%
↓ 94% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
-2051.19%
Historical baseline
PeriodValueYoY Change
2025-3982.39%-81.6%
2024-2193.46%-300.5%
2023-547.74%+18.9%
2022-675.24%+76.4%
2021-2857.15%-